glp-1 dose You've reached your weight loss goal on medications – what now? Low-Dose and Microdose GLP-1 for

Aging is an inevitable process, but science continues to unlock new ways to slow its effects

This work was supported by the Wilmot Cancer Institute Predoctoral Fellowship (G.A.), Wilmot Cancer Institute Pilot Funding (I.S.H.), the American Association for Cancer Research and Breast Cancer Research Foundation (20-20-26-HARR) (I.S.H.), Breast Cancer Coalition of Rochester (I.S.H.), a Sir Henry Wellcome Postdoctoral Fellowship (M.E.K.), and a FNR-CORE grant C21/BM/15796788 (D.B.), and NIH grants R01CA269813 (I.S.H.), R37CA230042 (G.M.D), R24AA022057 (V.V.), R01AA028859 (Y.C.), AI150698 (J.M.), K01CA240533-01A1 (C.L.C.), and R01AR078000 (R.T.D.)

This has resulted in the number of American adults taking GLP-1s increasing by 587% over the last five years

Livingstone R, Boyle JG, Petrie JR

LifeWaves Y-Age product line includes a series of non-transdermal patches that leverage the bodys natural energy to promote health and longevity